CTLA4 and cancer: Cancer immunotherapies have been hailed as the fourth pillar of cancer treatment and its great success in the clinic has led to the Nobel prize recently being awarded to James Allison and Tasuku Honjo for recognition of their discovery of the checkpoint molecules CTLA-4 and PD-1 respectively.